Theriva Biologics (TOVX) Operating Leases (2019 - 2026)
Theriva Biologics (TOVX) posted quarterly Operating Leases of $1.5 million for Q1 2026, up 107.92% year-over-year from $732000.0 in Q1 2025, and up 332.39% quarter-over-quarter from $352000.0 in Q4 2025.
Theriva Biologics (TOVX) Operating Leases (2019 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Operating Leases for 8 consecutive years, with $1.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases rose 107.92% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (up 107.92% YoY), while the FY2025 annual figure was $352000.0, down 59.68% from the prior year.
- Operating Leases rose to $1.5 million in Q1 2026 per TOVX's latest filing, from $352000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.8 million in Q1 2023 and bottomed at $352000.0 in Q4 2025.
- Historically, Operating Leases has averaged $1.2 million across 5 years, with a median of $1.2 million in 2022.
- Annual changes were most pronounced in 2022 — Operating Leases surged 1267.59% — and 2025, when it plunged 59.68%.
- Theriva Biologics' Operating Leases stood at $1.2 million in 2022, then gained by 21.48% to $1.4 million in 2023, then slumped by 39.46% to $873000.0 in 2024, then slumped by 59.68% to $352000.0 in 2025, then jumped by 332.39% to $1.5 million in 2026.
- Business Quant data shows TOVX's Operating Leases at $1.5 million in Q1 2026, $352000.0 in Q4 2025, and $433000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Theriva Biologics | 10.86 Mn | 10.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | 352,000.00 |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 584,000.00 |
| Mar 31, 2025 | 732,000.00 |
| Dec 31, 2024 | 873,000.00 |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.80 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 1.24 Mn |
| Jun 30, 2022 | 1.30 Mn |
| Mar 31, 2022 | 1.48 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 1.58 Mn |